The transcatheter mitral valve market size has grown strongly in recent years. It will grow from $1.61 billion in 2025 to $1.76 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to limited availability of transcatheter mitral valves, reliance on surgical valve replacement, growing awareness of mitral valve disease, increasing hospital cardiac procedures, early adoption in high-risk patient groups.
The transcatheter mitral valve market size is expected to see strong growth in the next few years. It will grow to $2.49 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to technological advancement in transcatheter valve designs, rising geriatric population with mitral valve disorders, expansion of cardiac catheterization laboratories, increasing healthcare expenditure, adoption of minimally invasive cardiac intervention programs. Major trends in the forecast period include rising adoption of minimally invasive cardiac procedures, increasing use of self-expanding and balloon-expandable valves, expansion of edge-to-edge and chordal repair devices, growing prevalence of mitral valve diseases among elderly patients, integration of imaging and navigation systems for procedure accuracy.
The rising prevalence of heart diseases is expected to drive the growth of the transcatheter mitral valve market in the coming years. Heart diseases are conditions that impair the structure or function of the heart, reducing its efficiency in pumping blood. This increase is largely driven by aging populations, as age-related deterioration of the heart and blood vessels heightens the risk of conditions such as mitral valve regurgitation, heart failure, and arrhythmias. Transcatheter mitral valves help manage heart disease by repairing or replacing a damaged mitral valve, restoring proper blood flow between the heart’s chambers, improving cardiac function, and alleviating symptoms. For example, in December 2024, the National Center for Health Statistics, a US-based government agency, reported that the age-adjusted death rate in 2023 fell to 750.5 per 100,000 standard population, a 6% decrease from 798.8 in 2022. Therefore, the increasing prevalence of heart diseases is driving growth in the transcatheter mitral valve market.
Key players in the transcatheter mitral valve market are concentrating on developing advanced devices, such as transcatheter mitral valve replacement (TMVR) systems, to broaden treatment options for high-risk or inoperable patients. TMVR systems are minimally invasive devices that replace a damaged or diseased mitral valve with an artificial valve via a catheter-based approach, eliminating the need for open-heart surgery. For instance, in May 2025, Abbott Laboratories, a US-based medical device company, launched Tendyne, which received FDA approval. This self-expanding, nitinol-framed valve is available in multiple sizes to suit different anatomies and can be fully repositioned or retrieved during implantation. Delivered through a small chest incision, the system allows for a minimally invasive procedure typically completed in around 1.5 hours. Designed for quicker recovery, most patients can be discharged within three days, providing a transformative option for high-risk mitral valve patients without viable surgical alternatives.
In April 2024, TechWald Holding S.p.A., an Italy-based medical technology investment company, acquired Valcare Medical Inc. for an undisclosed sum. This acquisition aims to strengthen TechWald Holding’s presence in the structural heart device market, focusing on transcatheter mitral valve repair and replacement. The deal enhances its cardiovascular portfolio, accelerates Valcare’s device development and commercialization, and bolsters its position in minimally invasive heart valve therapies. Valcare Medical Inc., based in Israel, specializes in minimally invasive transcatheter treatments for mitral regurgitation.
Major companies operating in the transcatheter mitral valve market are Abbott Laboratories, Medtronic Inc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Private Limited, MicroPort Scientific Corporation, Venus Medtech Inc., Cardiac Dimensions Inc., JenaValve Technology Inc., Ancora Heart Inc, Peijia Medical Limited, Micro Interventional Devices Inc., 4C Medical Technologies Inc., NeoChord Inc., Xeltis AG, Valcare Medical Inc., Colibri Heart Valve LLC, MitrAssist Ltd., HighLife SAS, Navigate Cardiac Structures Inc., Cardiovalve Ltd.
North America was the largest region in the transcatheter mitral valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter mitral valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the transcatheter mitral valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the transcatheter mitral valve market by increasing costs for imported medical devices and specialized components such as self-expanding and balloon-expandable valves. Segments like transcatheter valve replacement and repair devices are most affected, particularly in regions such as North America and Asia-Pacific where imports constitute a major portion of supply. While tariffs have increased production costs and limited immediate accessibility, they have also encouraged local manufacturing initiatives, domestic innovation, and diversification of supply chains, supporting long-term market growth.
The transcatheter mitral valve market research report is one of a series of new reports that provides transcatheter mitral valve market statistics, including transcatheter mitral valve industry global market size, regional shares, competitors with a transcatheter mitral valve market share, detailed transcatheter mitral valve market segments, market trends and opportunities, and any further data you may need to thrive in the transcatheter mitral valve industry. This transcatheter mitral valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A transcatheter mitral valve is a minimally invasive device designed to repair or replace a damaged mitral valve without requiring open-heart surgery. It is delivered to the heart via a thin catheter inserted through a vein or artery, improving blood flow and alleviating symptoms associated with mitral valve disease. This approach is particularly beneficial for patients at high risk for traditional surgical procedures.
The primary product types of transcatheter mitral valves include transcatheter mitral valve replacement and transcatheter mitral valve repair. Transcatheter mitral valve replacement involves inserting a new artificial or biological mitral valve into the heart using a catheter, usually through a blood vessel. It is indicated for conditions such as mitral stenosis and mitral regurgitation and is utilized by various end users, including hospitals, ambulatory surgical centers, and cardiac catheterization laboratories.
The transcatheter mitral valve market consists of sales of transcatheter annuloplasty devices, guiding catheters, chordal repair devices, and adjunctive imaging and navigation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The transcatheter mitral valve market size is expected to see strong growth in the next few years. It will grow to $2.49 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to technological advancement in transcatheter valve designs, rising geriatric population with mitral valve disorders, expansion of cardiac catheterization laboratories, increasing healthcare expenditure, adoption of minimally invasive cardiac intervention programs. Major trends in the forecast period include rising adoption of minimally invasive cardiac procedures, increasing use of self-expanding and balloon-expandable valves, expansion of edge-to-edge and chordal repair devices, growing prevalence of mitral valve diseases among elderly patients, integration of imaging and navigation systems for procedure accuracy.
The rising prevalence of heart diseases is expected to drive the growth of the transcatheter mitral valve market in the coming years. Heart diseases are conditions that impair the structure or function of the heart, reducing its efficiency in pumping blood. This increase is largely driven by aging populations, as age-related deterioration of the heart and blood vessels heightens the risk of conditions such as mitral valve regurgitation, heart failure, and arrhythmias. Transcatheter mitral valves help manage heart disease by repairing or replacing a damaged mitral valve, restoring proper blood flow between the heart’s chambers, improving cardiac function, and alleviating symptoms. For example, in December 2024, the National Center for Health Statistics, a US-based government agency, reported that the age-adjusted death rate in 2023 fell to 750.5 per 100,000 standard population, a 6% decrease from 798.8 in 2022. Therefore, the increasing prevalence of heart diseases is driving growth in the transcatheter mitral valve market.
Key players in the transcatheter mitral valve market are concentrating on developing advanced devices, such as transcatheter mitral valve replacement (TMVR) systems, to broaden treatment options for high-risk or inoperable patients. TMVR systems are minimally invasive devices that replace a damaged or diseased mitral valve with an artificial valve via a catheter-based approach, eliminating the need for open-heart surgery. For instance, in May 2025, Abbott Laboratories, a US-based medical device company, launched Tendyne, which received FDA approval. This self-expanding, nitinol-framed valve is available in multiple sizes to suit different anatomies and can be fully repositioned or retrieved during implantation. Delivered through a small chest incision, the system allows for a minimally invasive procedure typically completed in around 1.5 hours. Designed for quicker recovery, most patients can be discharged within three days, providing a transformative option for high-risk mitral valve patients without viable surgical alternatives.
In April 2024, TechWald Holding S.p.A., an Italy-based medical technology investment company, acquired Valcare Medical Inc. for an undisclosed sum. This acquisition aims to strengthen TechWald Holding’s presence in the structural heart device market, focusing on transcatheter mitral valve repair and replacement. The deal enhances its cardiovascular portfolio, accelerates Valcare’s device development and commercialization, and bolsters its position in minimally invasive heart valve therapies. Valcare Medical Inc., based in Israel, specializes in minimally invasive transcatheter treatments for mitral regurgitation.
Major companies operating in the transcatheter mitral valve market are Abbott Laboratories, Medtronic Inc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Private Limited, MicroPort Scientific Corporation, Venus Medtech Inc., Cardiac Dimensions Inc., JenaValve Technology Inc., Ancora Heart Inc, Peijia Medical Limited, Micro Interventional Devices Inc., 4C Medical Technologies Inc., NeoChord Inc., Xeltis AG, Valcare Medical Inc., Colibri Heart Valve LLC, MitrAssist Ltd., HighLife SAS, Navigate Cardiac Structures Inc., Cardiovalve Ltd.
North America was the largest region in the transcatheter mitral valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter mitral valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the transcatheter mitral valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the transcatheter mitral valve market by increasing costs for imported medical devices and specialized components such as self-expanding and balloon-expandable valves. Segments like transcatheter valve replacement and repair devices are most affected, particularly in regions such as North America and Asia-Pacific where imports constitute a major portion of supply. While tariffs have increased production costs and limited immediate accessibility, they have also encouraged local manufacturing initiatives, domestic innovation, and diversification of supply chains, supporting long-term market growth.
The transcatheter mitral valve market research report is one of a series of new reports that provides transcatheter mitral valve market statistics, including transcatheter mitral valve industry global market size, regional shares, competitors with a transcatheter mitral valve market share, detailed transcatheter mitral valve market segments, market trends and opportunities, and any further data you may need to thrive in the transcatheter mitral valve industry. This transcatheter mitral valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A transcatheter mitral valve is a minimally invasive device designed to repair or replace a damaged mitral valve without requiring open-heart surgery. It is delivered to the heart via a thin catheter inserted through a vein or artery, improving blood flow and alleviating symptoms associated with mitral valve disease. This approach is particularly beneficial for patients at high risk for traditional surgical procedures.
The primary product types of transcatheter mitral valves include transcatheter mitral valve replacement and transcatheter mitral valve repair. Transcatheter mitral valve replacement involves inserting a new artificial or biological mitral valve into the heart using a catheter, usually through a blood vessel. It is indicated for conditions such as mitral stenosis and mitral regurgitation and is utilized by various end users, including hospitals, ambulatory surgical centers, and cardiac catheterization laboratories.
The transcatheter mitral valve market consists of sales of transcatheter annuloplasty devices, guiding catheters, chordal repair devices, and adjunctive imaging and navigation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Transcatheter Mitral Valve Market Characteristics
3. Transcatheter Mitral Valve Market Supply Chain Analysis
4. Global Transcatheter Mitral Valve Market Trends and Strategies
5. Transcatheter Mitral Valve Market Analysis of End Use Industries
7. Global Transcatheter Mitral Valve Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Transcatheter Mitral Valve Total Addressable Market (TAM) Analysis for the Market
9. Transcatheter Mitral Valve Market Segmentation
10. Transcatheter Mitral Valve Market Regional and Country Analysis
11. Asia-Pacific Transcatheter Mitral Valve Market
12. China Transcatheter Mitral Valve Market
13. India Transcatheter Mitral Valve Market
14. Japan Transcatheter Mitral Valve Market
15. Australia Transcatheter Mitral Valve Market
16. Indonesia Transcatheter Mitral Valve Market
17. South Korea Transcatheter Mitral Valve Market
18. Taiwan Transcatheter Mitral Valve Market
19. South East Asia Transcatheter Mitral Valve Market
20. Western Europe Transcatheter Mitral Valve Market
21. UK Transcatheter Mitral Valve Market
22. Germany Transcatheter Mitral Valve Market
23. France Transcatheter Mitral Valve Market
24. Italy Transcatheter Mitral Valve Market
25. Spain Transcatheter Mitral Valve Market
26. Eastern Europe Transcatheter Mitral Valve Market
27. Russia Transcatheter Mitral Valve Market
28. North America Transcatheter Mitral Valve Market
29. USA Transcatheter Mitral Valve Market
30. Canada Transcatheter Mitral Valve Market
31. South America Transcatheter Mitral Valve Market
32. Brazil Transcatheter Mitral Valve Market
33. Middle East Transcatheter Mitral Valve Market
34. Africa Transcatheter Mitral Valve Market
36. Transcatheter Mitral Valve Market Competitive Landscape and Company Profiles
37. Transcatheter Mitral Valve Market Other Major and Innovative Companies
40. Transcatheter Mitral Valve Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Transcatheter Mitral Valve Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses transcatheter mitral valve market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for transcatheter mitral valve? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transcatheter mitral valve market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Transcatheter Mitral Valve Replacement; Transcatheter Mitral Valve Repair2) By Indication: Mitral Stenosis; Mitral Regurgitation
3) By End-User: Hospitals; Ambulatory Surgical Centers; Cardiac Catheterization Laboratories
Subsegments:
1) By Transcatheter Mitral Valve Replacement: Self-Expanding Valves; Balloon-Expandable Valves2) By Transcatheter Mitral Valve Repair: Annuloplasty Devices; Chordal Repair Devices; Edge-To-Edge Repair Devices
Companies Mentioned: Abbott Laboratories; Medtronic Inc; Boston Scientific Corporation; Edwards Lifesciences Corporation; Meril Life Sciences Private Limited; MicroPort Scientific Corporation; Venus Medtech Inc.; Cardiac Dimensions Inc.; JenaValve Technology Inc.; Ancora Heart Inc; Peijia Medical Limited; Micro Interventional Devices Inc.; 4C Medical Technologies Inc.; NeoChord Inc.; Xeltis AG; Valcare Medical Inc.; Colibri Heart Valve LLC; MitrAssist Ltd.; HighLife SAS; Navigate Cardiac Structures Inc.; Cardiovalve Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Transcatheter Mitral Valve market report include:- Abbott Laboratories
- Medtronic Inc
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Meril Life Sciences Private Limited
- MicroPort Scientific Corporation
- Venus Medtech Inc.
- Cardiac Dimensions Inc.
- JenaValve Technology Inc.
- Ancora Heart Inc
- Peijia Medical Limited
- Micro Interventional Devices Inc.
- 4C Medical Technologies Inc.
- NeoChord Inc.
- Xeltis AG
- Valcare Medical Inc.
- Colibri Heart Valve LLC
- MitrAssist Ltd.
- HighLife SAS
- Navigate Cardiac Structures Inc.
- Cardiovalve Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.76 Billion |
| Forecasted Market Value ( USD | $ 2.49 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
